Decreasing trends in HbA1c are visible when using the average HbA1c for each dataset for T1Ds, but not T2Ds. by Hans F. Dias (14486401)

CHIKV-infected primary joint tissue fibroblasts display decreased MHC-I cell surface expression. by Brian C. Ware (8544672)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

Cells expressing nsP2 inefficiently present antigen and have decreased levels of cell surface MHC-I. by Brian C. Ware (8544672)

Cue ratings during the test phase. by Anna-Lena Zillig (17350561)

Subjects:

Affective cue ratings during the test phase. by Anna-Lena Zillig (17350561)

Subjects:

Pain intensity ratings and pain unpleasantness ratings averaged across cues. by Anna-Lena Zillig (17350561)

Subjects:

Decreased <i>Bgl-</i>FaNaC expression in the visceral ganglion following <i>S</i>. <i>mansoni</i> infection. by Laura C. Vicente-Rodríguez (16437803)

“…Dunnett’s <i>post hoc</i> test: *, <i>p</i> < 0.05. See values in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0011249#pntd.0011249.t001" target="_blank">Table 1</a>. …”

Predictive value of RVT1 for the decreased RV ejection fraction (RVEF) and poor outcome in pulmonary arterial hypertension (PAH). by Ryotaro Asano (11767131)

“…(b) Relationships between changes in the RVEF and baseline RVT1. (c) The receiver characteristics curve analysis for a decreased RVEF at follow-up. …”

Cell-penetrating 15mer peptides decrease the proliferation and viability of cancer cells. by Pavan Kumar Puvvula (10495853)

Decreased <i>Bgl-</i>FaNaC expression in the left parietal ganglion following <i>S</i>. <i>mansoni</i> infection. by Laura C. Vicente-Rodríguez (16437803)

“…<p><b>a-c:</b> Decreased <i>Bgl</i>-FaNaC hybridization on the dorsal surface of the left parietal ganglion in infected specimens. …”

Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. by Mark P. Labrecque (10011469)

Solid Cure of Poly(phenylene sulfide): Competition between Increasing Nucleation Density and Decreasing Growth Rate by Hong Yin (20329)

“…The competitive results between increasing primary nucleation density and decreasing growth rate gave different isothermal crystallization rate versus cure time patterns for these two groups. …”

Solid Cure of Poly(phenylene sulfide): Competition between Increasing Nucleation Density and Decreasing Growth Rate by Hong Yin (20329)

“…The competitive results between increasing primary nucleation density and decreasing growth rate gave different isothermal crystallization rate versus cure time patterns for these two groups. …”

Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

Effects of 254- or 222-UVC exposure on <i>C</i>. <i>elegans</i> motility. by Kaoru Okamoto Yoshiyama (14526661)

Subjects:

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…See <b><a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001230#pbio.3001230.s006" target="_blank">S1 Data</a></b> for details of <i>p</i>-values and the type of statistical model used for all graphs in this study. …”

Outcomes: cure and relapse rates according to the intent to treatment approach. by Janaína de Pina Carvalho (12152812)

Subjects:

Mean pain intensity ratings and pain unpleasantness ratings, averaged across cues, separately for both groups. by Anna-Lena Zillig (17350561)

Subjects:

The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

“…This change was mostly attributable to change in the late AUC C-peptide response (i.e., 60-to-120-minute AUC C-peptide). Median Index60 values of  DPT-1 (1.44) and TNPTP (1.05) progressors to type 1 diabetes 1.5 years pre-diagnosis (time of transition from increasing to decreasing AUC C-peptide) were used as thresholds to identify individuals at high risk for type 1 diabetes in the full cohort at baseline (5-year risk of 0.75-0.88 for those above thresholds). …”